Analyst Consensus ?
ConsensusBuy23 ratings
Bullish1460.9%
Neutral730.4%
Bearish28.7%
FN2 Earnings Intelligence
Roper Technologies, Inc. analyst ratings
Roper Technologies, Inc. (ROP) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$436.33Current
$355Low
$517.46Average
$665High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Neutral | Underweight | Upgrade | Oct 26, 2026 |
| Truist Securities | Buy | Buy | Maintain | Oct 23, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Oct 23, 2026 |
| Jefferies | Buy | Buy | Maintain | Oct 23, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 23, 2026 |
| Argus Research | Buy | Hold | Upgrade | Aug 6, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 24, 2026 |
| Barclays | Underweight | Underweight | Maintain | Apr 24, 2026 |
| Baird | Outperform | Outperform | Maintain | Apr 24, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jan 29, 2026 |
| Stifel | Hold | Buy | Downgrade | Jan 28, 2026 |
| Oppenheimer | Perform | Outperform | Downgrade | Jan 28, 2026 |
| Mizuho | Underperform | Underperform | Maintain | Jan 28, 2026 |
| TD Cowen | Buy | Buy | Maintain | Oct 24, 2025 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Oct 24, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jun 13, 2024 |
| Wells Fargo | Overweight | Overweight | Maintain | Jan 22, 2024 |
| Bernstein | Outperform | Market Perform | Upgrade | May 2, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jul 26, 2022 |
| Stephens & Co. | Overweight | Overweight | Maintain | Apr 30, 2019 |
| Argus | Buy | Buy | Maintain | Aug 2, 2018 |
| Canaccord Genuity | Hold | Hold | Maintain | Feb 5, 2018 |
| Stifel Nicolaus | Buy | Buy | Maintain | Feb 2, 2016 |
Named analyst price targets
Upside is calculated against the persisted current price $436.34. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Terry Tillman | $500 | $436.54 | +14.6% | Oct 23, 2026 |
| BMO Capital | Daniel Jester | $462 | $434.56 | +5.9% | Oct 23, 2026 |
| RBC Capital | Analyst unavailable | $450 | $438.87 | +3.1% | Oct 23, 2026 |
| Jefferies | Analyst unavailable | $540 | $436.23 | +23.8% | Oct 22, 2026 |
| Argus Research | Analyst unavailable | $450 | $394.53 | +3.1% | Aug 6, 2026 |
| RBC Capital | Deane Dray | $417 | $370.27 | -4.4% | Jul 24, 2026 |
| Robert W. Baird | Analyst unavailable | $480 | $355.12 | +10.0% | Jul 24, 2026 |
| Piper Sandler | Clarke Jeffries | $526 | $355.12 | +20.5% | Jul 24, 2026 |
| Mizuho Securities | Analyst unavailable | $355 | $362.84 | -18.6% | Jul 21, 2026 |
| BMO Capital | Daniel Jester | $393 | $355.94 | -9.9% | Jul 10, 2026 |
| RBC Capital | Analyst unavailable | $407 | $363.76 | -6.7% | Apr 24, 2026 |
| Robert W. Baird | Analyst unavailable | $470 | $363.76 | +7.7% | Apr 24, 2026 |
| Piper Sandler | Analyst unavailable | $540 | $363.76 | +23.8% | Apr 24, 2026 |
| Barclays | Analyst unavailable | $373 | $363.76 | -14.5% | Apr 24, 2026 |
| Goldman Sachs | Analyst unavailable | $440 | $360.37 | +0.8% | Jan 29, 2026 |
| RBC Capital | Analyst unavailable | $398 | $360.66 | -8.8% | Jan 28, 2026 |
| Mizuho Securities | Analyst unavailable | $365 | $360.98 | -16.3% | Jan 28, 2026 |
| Robert W. Baird | Analyst unavailable | $550 | $358.34 | +26.0% | Jan 28, 2026 |
| Jefferies | Analyst unavailable | $500 | $369.27 | +14.6% | Jan 28, 2026 |
| Barclays | Analyst unavailable | $409 | $369.27 | -6.3% | Jan 28, 2026 |
| Stifel Nicolaus | Analyst unavailable | $385 | $369.27 | -11.8% | Jan 27, 2026 |
| Truist Financial | Terry Tillman | $550 | $369.27 | +26.0% | Jan 27, 2026 |
| Melius Research | Scott Davis | $479 | $355.89 | +9.8% | Jan 27, 2026 |
| Oppenheimer | Analyst unavailable | $525 | $407.48 | +20.3% | Jan 23, 2026 |
| Piper Sandler | Clarke Jeffries | $530 | $432.39 | +21.5% | Jan 13, 2026 |
| Jefferies | Analyst unavailable | $600 | $430.77 | +37.5% | Jan 5, 2026 |
| Mizuho Securities | Analyst unavailable | $419 | $434.54 | -4.0% | Jan 5, 2026 |
| Barclays | Analyst unavailable | $475 | $445.89 | +8.9% | Dec 4, 2025 |
| Piper Sandler | Clarke Jeffries | $600 | $444.78 | +37.5% | Nov 19, 2025 |
| Barclays | Analyst unavailable | $506 | $470.18 | +16.0% | Oct 27, 2025 |
| RBC Capital | Analyst unavailable | $539 | $478.8 | +23.5% | Oct 27, 2025 |
| Truist Financial | Analyst unavailable | $650 | $479.85 | +49.0% | Oct 24, 2025 |
| Stifel Nicolaus | Analyst unavailable | $550 | $479.96 | +26.0% | Oct 24, 2025 |
| RBC Capital | Deane Dray | $644 | $479.96 | +47.6% | Oct 24, 2025 |
| Robert W. Baird | Analyst unavailable | $592 | $479.96 | +35.7% | Oct 24, 2025 |
| Raymond James | Brian Gesuale | $575 | $479.51 | +31.8% | Oct 24, 2025 |
| Jefferies | Analyst unavailable | $650 | $479.96 | +49.0% | Oct 23, 2025 |
| Oppenheimer | Ken Wong | $570 | $479.96 | +30.6% | Oct 23, 2025 |
| Mizuho Securities | Brett Linzey | $510 | $500.08 | +16.9% | Oct 17, 2025 |
| Barclays | Julian Mitchell | $550 | $498.69 | +26.0% | Oct 1, 2025 |
| Mizuho Securities | Brett Linzey | $600 | $582.88 | +37.5% | May 16, 2025 |
| Oppenheimer | Christopher Glynn | $640 | $557.7 | +46.7% | Apr 28, 2025 |
| Stifel Nicolaus | Analyst unavailable | $685 | $582.71 | +57.0% | Mar 26, 2025 |
| Robert W. Baird | Joe Vruwink | $665 | $575.65 | +52.4% | Jan 31, 2025 |
| Truist Financial | Terry Tillman | $665 | $542.94 | +52.4% | Oct 24, 2024 |
| Robert W. Baird | Richard Eastman | $652 | $542.94 | +49.4% | Oct 24, 2024 |
| RBC Capital | Deane Dray | $666 | $542.94 | +52.6% | Oct 24, 2024 |
| Robert W. Baird | Joe Vruwink | $635 | $531.97 | +45.5% | Jul 25, 2024 |
| Barclays | Julian Mitchell | $625 | $550.47 | +43.2% | Jul 10, 2024 |
| Argus Research | John Eade | $575 | $511.46 | +31.8% | Apr 30, 2024 |
| Wolfe Research | Brad Hewitt | $625 | $543.01 | +43.2% | Apr 8, 2024 |
| Oppenheimer | Christopher Glynn | $650 | $556.38 | +49.0% | Mar 22, 2024 |
| Goldman Sachs | Analyst unavailable | $468 | $429.25 | +7.3% | Dec 15, 2022 |
| RBC Capital | Analyst unavailable | $565 | $472.01 | +29.5% | Apr 27, 2022 |
| Cowen & Co. | Joseph C Giordano | $520 | $487.88 | +19.2% | Jul 26, 2021 |
| Oppenheimer | Christopher Glynn | $560 | $494.71 | +28.3% | Jul 23, 2021 |
Track every rating change on ROP the moment it posts. Free to start.
Start freeGet the ROP recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.